In this study, we established PCOs and isolated CAFs from human pancreatic cancer tissues, and the KRAS G12D mutation was identified in pancreatic cancer tissues and all established organoid lines (Table S2). The gene discussed is KRAS; the disease is familial pancreatic carcinoma.